AQFluoroTech Co., Ltd. was founded in 2013 as a wholly-owned subsidiary of Aqbiopharma (Shanghai) Co., Ltd.
Aqbiopharma (Shanghai) Co., Ltd. is one of China’s early enterprises specializing in dedicated R&D of fluorinated new drugs and fluorinated pharmaceutical intermediates.
The company operates a 2,800 m² R&D and pilot testing center and a 51 mu (34,000 m²) industrial production base. After nearly 20 years of continuous investment and technological research, it has developed more than 3,000 mass-producible products. Multiple core process technologies and new drug research outcomes have been filed for invention patents, with a total of 30 patents granted.
Its main products cover a full range of fluorinated pharmaceutical intermediates, including heterocyclic fluorine building blocks such as piperidine, piperazine, pyrrolidine, azaindole, adamantane, aza-spirocycles and aza-fused rings. [view detail]
No content!
No content!